Showing results (1261-1270 of 1,400) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|August 17, 2022
Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid CarcinomaJennifer Rui Wang, Matthew Montierth, Li Xu, et al.
JCO Precision Oncology|February 14, 2023
Clearance Profile of Circulating Tumor Human Papillomavirus DNA During Radiotherapy Predicts Clinical Outcomes in Human Papillomavirus-Related Oropharyngeal CancerHidenori Tanaka, Atsuhiko Uno, Yukinori Takenaka, et al.
JCO Precision Oncology|March 6, 2025
Association Between Human Epidermal Growth Factor Receptor 2-Low Status and Time to Development of Brain Metastases Among Patients With Breast Cancer: A Retrospective Cohort StudyKevin Yijun Fan, Rania Chehade, Italo Fernandes, et al.
JCO Precision Oncology|February 21, 2025
Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial EmulationEmanuel Krebs, Deirdre Weymann, Cheryl Ho, et al.
JCO Precision Oncology|February 21, 2025
NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted TherapyVicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
JCO Precision Oncology|February 12, 2025
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape ProjectMartina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, et al.
JCO Precision Oncology|January 24, 2025
Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 TrialSun Young Rha, Yanqiao Zhang, Anneli Elme, et al.
JCO Precision Oncology|January 24, 2025
Association of Germline Pathogenic Variants in MUTYH and Other DNA Damage Response Genes With Lung Cancer Risk Among Non-Hispanic Whites and African AmericansMatthew R Trendowski, Christine M Lusk, Angela S Wenzlaff, et al.
JCO Precision Oncology|January 31, 2025
Quantitation of Plasma Proteins to Predict Taxane-Induced Peripheral NeuropathyNam Nguyen-Hoang, Yaping Liu, N Lynn Henry, et al.
JCO Precision Oncology|November 7, 2024
Updated Survival Follow-Up for Phase Ib Trial of the Histone Deacetylase Inhibitor Abexinostat With Pazopanib in Patients With Solid Tumor MalignanciesErica S Tsang, Rahul R Aggarwal, Emily K Bergsland, et al.
Pageof 140